Recruitment and retention of study subjects in clinical research is at an all-time low; the average retention rate in 2013 was 33% which is a 56% drop from 2003 levels. Patient centricity has to do with making the patient feel special, and therefore clinical trial participation attractive as well as more valuable to them. More importantly, an attitude of patient centricity helps with continuity of care, better diagnostic targeting and treatment outcomes, and thus retention.
We had the pleasure of sitting down with five leading clinical trial professionals to discuss how well clinical trials currently treat patients and to what extent patient-centricity is truly at the core of research. In this conversation, we look at the ways in which clinical research can be made more patient-friendly to enhance recruitment and retention, including wearable technology, social media, novel trial designs, data management, support groups and sensitivity to minorities.
The panel of experts providing these exclusive insights were;
- Susan Windham-Bannister, PhD, President & CEO, Biomedical Growth Strategies
- Nikola Strumberger, MD, Clinical Operations Director, OptimaPharm
- William Tannenbaum, Co-Head of Technology Transactions Practice, Arent Fox
- Dr. Timothy Low, CEO, Farrer Park Hospital, Singapore
- Dr. Piyush Gupta, Associate Director of Business Development, GNH India
Interested in learning more? Join us at T3: Trials, Tech and Transformation in Orlando, FL this May. Save $200 with the VIP code: T3BLOG17 | Click here to learn more.